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7RESEARCH ARTICLE Open AccessTranscriptional response to cardiac injury in the
zebrafish: systematic identification of genes with
highly concordant activity across in vivo models
Sophie Rodius1, Petr V Nazarov2, Isabel A Nepomuceno-Chamorro3, Céline Jeanty1, Juan Manuel González-Rosa4,
Mark Ibberson5, Ricardo M Benites da Costa6, Ioannis Xenarios5,6,7, Nadia Mercader8 and Francisco Azuaje1*Abstract
Background: Zebrafish is a clinically-relevant model of heart regeneration. Unlike mammals, it has a remarkable
heart repair capacity after injury, and promises novel translational applications. Amputation and cryoinjury models are
key research tools for understanding injury response and regeneration in vivo. An understanding of the transcriptional
responses following injury is needed to identify key players of heart tissue repair, as well as potential targets for
boosting this property in humans.
Results: We investigated amputation and cryoinjury in vivo models of heart damage in the zebrafish through unbiased,
integrative analyses of independent molecular datasets. To detect genes with potential biological roles, we derived
computational prediction models with microarray data from heart amputation experiments. We focused on a
top-ranked set of genes highly activated in the early post-injury stage, whose activity was further verified in
independent microarray datasets. Next, we performed independent validations of expression responses with
qPCR in a cryoinjury model. Across in vivo models, the top candidates showed highly concordant responses at 1 and
3 days post-injury, which highlights the predictive power of our analysis strategies and the possible biological relevance
of these genes. Top candidates are significantly involved in cell fate specification and differentiation, and include heart
failure markers such as periostin, as well as potential new targets for heart regeneration. For example, ptgis and ca2
were overexpressed, while usp2a, a regulator of the p53 pathway, was down-regulated in our in vivo models.
Interestingly, a high activity of ptgis and ca2 has been previously observed in failing hearts from rats and humans.
Conclusions: We identified genes with potential critical roles in the response to cardiac damage in the zebrafish. Their
transcriptional activities are reproducible in different in vivo models of cardiac injury.
Keywords: Myocardial infarction, Zebrafish, Ventricular amputation, Ventricular cryoinjury, Heart regeneration,
Transcriptional responses, Transcriptional association networksBackground
The zebrafish (Danio rerio) has the capacity to regenerate
its heart after undergoing severe injury [1,2]. This capabil-
ity has been shown in adult zebrafish using different
in vivo models of cardiac damage, and involves the gener-
ation of new cardiomyocytes from existing ones located
near the injury site [3,4]. Thus, the zebrafish represents a
compelling model to study heart injury and regeneration
with potential clinical impact. In the long-term, this will* Correspondence: francisco.azuaje@crp-sante.lu
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unless otherwise stated.be crucial to address a major world-wide public health
problem: heart attacks (myocardial infarction) followed
by heart failure [5]. The latter is a consequence of the
incapacity of the human heart to replace the lost cardi-
omyocytes by newly formed myocardium, instead
forming an irreversible fibrotic scar [6,7].
Identification of the cellular and molecular mechanisms
of zebrafish heart regeneration might thus allow to find
new therapeutic approaches for the treatment of myo-
cardial infarction in humans. Despite obvious differences
between teleosts and mammals, the sequencing of the
zebrafish genome revealed that about 70% of human genesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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of genetic screens have already been performed in zeb-
rafish in order to identify genes involved in cardiac
development and regeneration. Random mutagenesis,
creation of transgenic strains using inducible genetic
approaches or targeted gene inactivation using morpholi-
nos have led to generation of different models of human
cardiac disorders [9-16], whose number will undoubtedly
be expanded by new genome editing techniques, such as
Crisp/Cas9 and TALEN. Moreover, the external develop-
ment of the zebrafish embryo and its transparency allows
direct microscopic observation of cardiovascular structures
without invasive instrumentation. Coupled to its ability to
survive for several days without functional cardiovascular
system, catching oxygen by passive diffusion [17], these
attributes make zebrafish particularly suitable to study
the phenotype of cardiovascular diseases. Besides, response
to drugs is well conserved between fish and mammals [18],
making zebrafish a widely used model for toxicological ana-
lysis and to study the possible cardiac effects of chemical
compounds.
Different techniques have been set up to study the re-
markable cardiac regeneration ability of adult zebrafish.
Coronary artery ligation, mimicking ischemic injury that
leads to myocardial infarction in human, is commonly
used as model of myocardial infarction in mice. However,
the size of the ventricle (around 1 mm3) renders this kind
of injury almost impossible to achieve in zebrafish. Conse-
quently, different alternative models have been used to
study myocardial infarction in adult zebrafish: ventricular
amputation, cryoinjury and cell-type specific ablation
[19,20]. The oldest and most widely used technique is
ventricular amputation, which consists of removing about
20% of the apex of the ventricle by surgical resection. Fol-
lowing surgery, the apex is sealed by a clot of erythrocytes,
further replaced by fibrin. Two months post-injury, the
clot is not replaced by scar tissue but by cardiac muscle
formed by cardiomyocytes proliferation, restoring the
contractile properties of the heart [21]. More recently, the
cryocauterization model, which is already used in mouse
[22], has been applied to zebrafish. In this technique, a
cryoprobe or dry ice is used to freeze 15 to 25% of the
ventricle [23-27]. Following cryocauterization, blood accu-
mulates in the infarct area and massive cell death can be
observed at the injury site. A large fibrotic scar is formed
and further replaced by cardiac tissue following cardio-
myocytes proliferation. Total recovery is longer than for
ventricular amputation (up to 130 days [23]), which may
be due to the extra time needed to remove the necrotic
tissue and heal the scar. Finally, a genetic cell ablation
model based on the Cre-lox strategy was set up to specif-
ically kill cardiomyocytes in an inducible manner through-
out the heart [28]. This technique allows destruction of
60% of cardiomyocytes and promotes signs of cardiacfailure. Upon cell death, inflammatory cells are recruited,
endocardial and epicardial cells are activated and cardio-
myocytes de-differentiation and proliferation are enhanced,
leading to muscle regeneration by 1 month after injury.
Among these cardiac regeneration models, cryoinjury is
perhaps the most relevant for translational biomedical
research. It resembles what is observed in the human
heart following myocardial infarction, including the fact
that the injury affects all cardiac cell types and promotes
massive cell death and the formation of a fibrotic scar.
The analysis of transcriptional responses following injury
is a powerful approach to identifying candidate drivers of
heart repair and regeneration, which may represent poten-
tial targets for triggering or boosting cardiomyocyte renewal
in mice and humans [29,30]. Mainly using amputation and
genetic ablation models, several studies have characterized
differential expression responses at different times after
injury based on microarrays or in situ hybridization
techniques [31]. These techniques in combination with
generation of transgenic zebrafish strains and protein
concentration analysis have demonstrated the regulatory
roles of biological pathways implicated in cell proliferation
and differentiation, such as retinoic acid [32], platelet-
derived growth factor [31,33], sonic hedgehog, Insulin-like
growth factor, Transforming growth factor beta [34,35],
Jak1/Stat3 [30] and Notch signalling [36].
Despite the insights derived from previous research,
there is still a need to: a. apply biologically unbiased
approaches to dissecting transcriptional responses
after injury, and b. investigate the validity of relevant
findings across different in vivo models. The former in-
volves the characterization of gene expression patterns
beyond the identification of genes differentially expressed.
The latter is important not only to reconcile different
in vivo models that are promising for translational re-
search, but also to identify genes with post-injury tran-
scriptional behaviours that are highly robust regardless of
injury model. Previous investigations conducted by our
team and elsewhere have demonstrated that the application
of network-based approaches to gene expression analysis
can: 1. enhance systems-level understanding of key bio-
logical states; and 2. identify candidate markers of cardiac
damage, which are not only accurate for sample classifica-
tion but also reproducible in independent datasets and
model organisms.
Here, our main objective is to identify genes exhibiting
important transcriptional perturbations after heart injury
in the zebrafish, which are both biologically meaningful
and reproducible in independent in vivo models.
To address this question, we applied different computa-
tional analysis strategies with an emphasis on network-
based approaches, which identify significant gene-gene as-
sociations from the expression data. Our key premise was
that genes with prominent patterns of “transcriptional
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potential critical roles in the response to injury. Here,
we show that across in vivo models, a set of top candidates
showed highly concordant responses at 1 and 3 days post-
injury (dpi). This set of computationally predicted candi-
dates are significantly associated with processes relevant
to cell fate specification and differentiation. They include
genes with suspected functional roles in heart regener-
ation, as well as novel genes that may exercise influential
roles in the early stages of injury response.
Results
Overview of discovery framework
Figure 1 summarises our analytical and modelling work-
flow. First, we analysed a published dataset that consists
of gene expression measurements of sham-operated and
injured hearts at 1, 3, 5 and 7 days post-amputation [29].
From now on, we will refer to this dataset as the model
derivation dataset. We detected genes significantly differ-
entially expressed across all samples, and selected them
for further analysis. We then applied three published com-
putational approaches to generating and analysing gene
co-expression networks: Clustering with Overlapping
Neighborhood Expansion (ClusterONE) [37], inferenceFigure 1 Overview of analytical and modelling workflow.of gene regression networks with model trees (RegNet)
[38], and the Weighted Gene Co-Expression Network
(WGCNA) algorithm [39]. This allowed us to identify:
networks clusters, highly connected genes, and genes
that can be used as estimators of the expression values
of other genes in the dataset (Methods). We independ-
ently performed these analyses, focused on (statistically)
top-ranked results, and selected a list of candidate genes
for further computational and experimental analysis. In
the validation phase, we implemented the cryoinjury
model at our laboratory and measured the expression of
the candidate genes by RT-qPCR (Methods). From now
on, we will refer to this dataset as the model validation
dataset. In the network models reported here, nodes and
edges represent genes and between-gene expression corre-
lations respectively.
Data pre-processing and differential expression analysis
Processed Affymetrix GeneChip Zebrafish microarray data
were downloaded from ArrayExpress (E-GEOD-17993)
resulting of 15617 features with 10773 unique gene symbol
[29]. Model derivation dataset consists of 15 microarrays: 3
replicates over 5 time points (control, 1, 3, 5 and 7 day
after operation). Pre-filtering of features decreased the size
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with unique gene symbol. Limma analysis resulted in 3403
unique annotated genes variable across the time points
with FDR < 0.05, 88 genes at FDR ≤ 0.0001. The number
of differentially expressed genes (FDR < 0.05) after apply-
ing 2-condition contrasts varied in time: 1907, 2349, 1914,
and 330 annotated genes for control vs. 1, 3, 5 and 7 days
respectively. Thus the highest dysregulation of the tran-
scriptome was observed at the 3rd day after injury, while
other important events required for heart regeneration
occur in the days following injury.
A second dataset comes from independent work by Kizil
et al. [40] (E-MEXP-1239). Here, 11 arrays were used: 4
controls replicates, 1 replicate for each of 6 hours, 12 hours
and 1 day, 2 replicates for 3 and 5 days. We were able
to identify only 34 differentially expressed genes with
FDR < 0.05 in this dataset.
Identification of potentially relevant genes with network-
based approaches
After computing between-gene correlations among top-
differentially expressed genes in the derivation dataset
(88 differentially expressed genes at FDR ≤ 0.0001), we
generated a gene co-expression network. This network
consisted of 3828 edges representing gene co-expression
relationships estimated with the Pearson correlation
coefficient, r. To reduce the number of potential spurious
associations and facilitate visualizations, we filtered out
edges with │r│ < 0.95. To verify the potential statistical
relevance of these associations, we estimated their
maximal information coefficients (MICs) and con-
firmed the high co-expression relationships of these
genes (MIC > 0.95). The resulting network included 86
nodes and 346 edges. A dynamic visualization of this
network at different time points and their underlying
data are available in Additional file 1. The ClusterONE
algorithm identified two highly statistically significant
network modules (Figure 2A): one consisting of 18
nodes and 79 edges (P = 1.4E-7), and another consisting
of 21 nodes and 107 edges (P = 3.3E-7). The first module
contained postnb (periostin b). Periostin is a known
fibroblast marker, which is found in the scar tissue in
both mouse and zebrafish [41-46]. While its role in
myocardial proliferation remains to be fully elucidated,
interestingly, its expression precedes heart regeneration
in the zebrafish [46], which is consistent with our find-
ings in two in vivo injury models. The second module
also includes potentially interesting genes, such as usp2a
(Ubiquitin Specific Peptidase 2) and mapk4 (Mitogen-
Activated Protein Kinase 4), which are implicated in cell
death and proliferation signalling pathways [47,48].
Independently, we applied the RegNet algorithm on the
reduced dataset (88 genes at FDR ≤ 0.0001) to extract tran-
scriptional association networks (Methods). This modellingtechnique specifies mathematical relationships between the
genes based on linear regression models. Such associations
are graphically represented with directed edges to indicate
which genes can be used as reliable estimators of the
expression values of other genes in the dataset
(Figure 2B). RegNet identified a statistically significant
network (alpha = 0.05, which is set to control the FDR
using Benjamin-Yekutieli procedure, and theta = 30%,
which is set as a relative error threshold) containing 8
nodes and 7 edges (Figure 2B), which overlaps with the
modules identified previously (Figure 2A). In this network,
ptgis (Prostaglandin I2 synthase) is shown as the central
node, and its expression data are correlated (positively
and negatively) with the other genes in the network. This
allows a qualitative labelling of each network edge with
the direction of the observed gene-gene associations. For
example, ptgis is negatively correlated with acta1a (upper
gene in Figure 2B). This means that the expression values
of these genes have opposite responses in the dataset.
Therefore, we can use the sign of these associations to
tag the direction of the relationship between ptgis and
the other genes: UP (positive association) and DOWN
(negative association). These results highlight ptgis as a
candidate relevant gene based on its potential to estimate
the expression response of other genes in the dataset.
To further assess the potential predictive relevance and
robustness of these findings, we applied the WGCNA
algorithm to a larger version of the dataset: 3403 differ-
entially expressed genes at FDR ≤ 0.05, and with gene
associations calculated with the Spearman correlation
coefficient. As in the results from ClusterONE and
RegNet, WGCNA found a strong association between
ptgis and acta1a within the same network module consist-
ing of 1013 genes (Figure 2C, high resolution version in
Additional file 2). For ptgis, WGCNA reports a very high
module membership (MM) score of 0.95 (P = 2.3E-08),
which also highlights the prominent centrality of ptgis
within this highly interconnected module. In this module
acta1a shows a MM= −0.9 (P = 4.9E-06) that not only
indicates its negative correlation with ptgis, but also its
multiple strong connections with the other members of
this module. We repeated this analysis on a network gen-
erated with Pearson correlations, and consistent associa-
tions between ptgis (MM= 0.9) and acta1a (MM= −0.87)
were detected within the same, though smaller, module
(616 genes). These results gave us further evidence of the
potential relevance of the association between ptgis and
acta1a.
As we are interested in identifying genes with robust
and reproducible transcriptional responses, we comple-
mented our findings with an analysis of concordant gene
expression patterns in relation to an independent dataset
[40]. As in our model derivation dataset, Kizil et al.’s data-
set was obtained from microarray measurements from a
Figure 2 Computational models generated from public data. Different approaches highlight genes and associations with potential influential
roles in response to injury. A. Top network modules identified with the ClusterONE algorithm [37]. Network nodes shown as rectangles: genes
with exclusive membership in the modules shown, diamonds: genes with multiple module membership. Edges represent co-expression associations.
B. Top candidate regulatory circuit inferred with the RegNet algorithm [38]. Edges represent gene co-expression association, with arrows defining the
direction of the association between ptgis and the other genes according to linear regression models. The latter are shown for each gene-gene
association. C. Snapshot of network module identified with the WGCNA algorithm, which contains genes involved in A and B, including ptgis
(higher resolution image in Additional file 2). D. List of genes with significant concordant expression values between our model derivation dataset [29]
and a dataset obtained from an independent study based on amputation model [40]. Between-dataset correlation values are shown.
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derivation dataset, Kizil et al.’s dataset exhibited a reduced
set of significantly differentially expressed genes (34 genes
differentially expressed at FDR < 0.05) across control
and post-injury samples. We searched for highly con-
cordant expression response between these two datasets
(Pearson correlation > 0.8) at control and days 1, 3 and
5 post-injury. Figure 2D displays the resulting list of
genes with strong between-dataset expression correla-
tions. Although none of these genes were highlighted as
potentially relevant by our network-based approaches,
they deserved further investigation based on their highly
robust behaviour in independent studies. Moreover, we
note that mmp13a (matrix metalloproteinase 13a) and
LOC100332348 (an uncharacterized protein coding gene)
were found together with ptgis and acta1a in the same
WGCNA module.Selection of candidate genes for independent
experimental validation
Next, we selected a list of genes for independent experi-
mental validation at our laboratory. Among the genes that
were identified above as potentially relevant, we decided
to focus our attention on 15 genes that met the following
criteria: a. genes that were highlighted by at least one of
the techniques reported above, b. genes that have not been
functionally characterized in the zebrafish or associated
with its heart regeneration capacity, c. genes with un-
ambiguous and accurate matching qPCR primers for
the zebrafish genome. Additionally, we included postnb
because of its known activity in the early stages of
heart regeneration in zebrafish. Figure 3A shows the
list of selected candidate genes, and a summary of their
expression responses in the model derivation dataset.
In this visualisation we also plot the probe-specific
Figure 3 Candidate genes: their transcriptional responses and potential functional implication. A: Summary of expression patterns displayed
by set of top candidates. Level of the statistical significance of their expression changes across samples are shown with their corresponding FDR
values. B: Statistically significant associations between candidate genes and biological processes detected by IMP (FDR-corrected P-values < 0.05) [49].
Plot shows –log10(P-values).
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http://www.biomedcentral.com/1471-2164/15/852expression levels for those genes with multiple micro-
array probes in the model derivation dataset. Such
cases show high expression consistency within the
dataset.
After selecting the candidate genes, we detected statisti-
cally significant associations between this gene set and cel-
lular processes with the IMP (Integrative Multi-species
Prediction) system [49]. IMP identified 20 significant
associations (FDR-corrected P-values < 0.05) between
our candidate genes and diverse cellular processes rele-
vant or related to cell proliferation, differentiation and
cell-cell interactions (Figure 3B). Some are specifically
related to mesoderm and endoderm development. Inter-
estingly, while cardiomyocytes derive from the mesoderm,
factors secreted by the endoderm are necessary to induce
differentiation of the mesoderm in heart tissue during em-
bryonic development [50-54]. We might speculate that
the crosstalk between endodermal and mesodermal cells
that allows to regulate cardiogenesis during vertebrate
embryonic development may be re-activated following
myocardial infarction in adult to promote cardiac regener-
ation. These computational predictions, made by IMP
based on the analysis of diverse independent molecular
datasets, further demonstrate the potential relevance of
our candidate genes.
Also we assessed the transcriptional concordance of
our candidate genes in relation to the dataset by Lien
et al.’s [30]. We detected a high positive correlation in
their responses (log2FC) at 3 dpi (Pearson correlation,
r = 0.955). Moreover, there is a positive linear correlation
at day 7 (r = 0.636). These analyses provide further evi-
dence of the robust responses of our candidate genes
across time and in vivo injury models. It is also worth not-
ing that the high concordance of our candidate genes at 3
dpi was detected despite the fact that Lien et al.’s dataset
shows a much smaller set of significantly differentially
expressed genes than our derivation dataset at 3dpi (326
vs. 1123 genes, FDR < 0.01).
Independent validation with a cryoinjury model
In order to independently validate, in vivo, the results
obtained from the analysis of public microarray data, we
induced myocardial infarction in zebrafish using the
cryoinjury technique. Experiments were performed on
WIK wild-type fish aged 10–11 months. For sham surgery,
we opened the body and the pericardial sac, without
touching the ventricle, as previously described [29]. Ani-
mals were sacrificed and hearts were recovered 1 or 3 days
post-surgery. Three independent experiments comparing
gene expression in sham vs. cryoinjured animals were per-
formed. In each experiment, the ventricle was separated
from the bulbus and the atrium following dissection, and
3 to 4 ventricles were pooled per sample in order to per-
form the qPCR validation. To visualize the cryoinjuredarea, we performed immunofluorescence stainings of the
ventricle of sham and cryoinjured animals. Hearts of
sham-operated animals expressed tropomyosin in the
whole ventricle and in the atrium, while tropomyosin
staining appeared very weak in the injured area one
day post-injury (Additional file 3). Furthermore, while
no apoptotic cells were visible in sham-operated
hearts, many TUNEL-positive cells were detected in
the lesioned area at day-1 post-injury (Additional file 3).
These results confirmed massive cell death of cardiomyo-
cytes in the injured area at day-1 following cryoinjury.
We measured the expression of the candidate genes
with qPCR 1 and 3 days after cryoinjury and from sham
operated animals (3 injured vs. 3 sham samples for each
time point). We assessed whether qPCR expression re-
sponses were consistent with those observed in the ampu-
tation model. We found a high concordance between the
expression responses at day-1 from the model derivation
and validation datasets (Figure 4). More specifically,
strong positive linear correlations were detected between
their (log2-transformed) expression fold-changes at day-1
(Pearson’s correlation, r = 0.77, P = 0.0008). Our validation
experiments at day-3 also showed that the transcriptional
response of our candidate genes is highly concordant be-
tween independent datasets and in vivo models. As before,
we observed a high positive correlation between the deriv-
ation and validation datasets (r = 0.84, Figure 5).
Next, we tested the capacity of the RegNet-derived net-
work (Figure 2B) to reproduce its predicted associations
in our cryoinjury model. From this network, the following
candidate genes were included in the independent qPCR
dataset: ptgis, ca2, usp2a, sgce and acta1. Thus, we
tested whether the following expression associations
were preserved:
A. ptgis and ca2 (positive association)
B. ptgis and usp2a (negative association)
C. ptgis and sgce (negative association)
D. ptgis and acta1 (negative association)
Figures 6 and 7 illustrate the results from this independ-
ent test, and indicate a good reproducibility of predicted
associations at day-1 and −3. This network model cor-
rectly described the qualitative gene-gene (fold-change)
relationships observed in the validation dataset. The only
exception to the latter was the response of sgce, which
showed a Log2FC = 0.003, instead of the negative value
predicted. An alternative visualization of the changes in
(log2) expression of these genes is available in Additional
file 4. This is further evidence of the predictive potential
of this network model, and of the putative relevance of
ptgis as a transcriptional control component in the early
response to heart injury in both amputation and cryoin-
jury models.
Figure 4 Candidate genes show significant concordance of expression patterns across independent in vivo models at day-1 post-injury.
Log2-transformed fold-changes (FC) observed at day-1 (in relation to controls). Independent observations show strong positive linear relationships
(Pearson correlation coefficient: 0.77, coefficient of determination: 0.59).
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The main contributions of our research are: a. based on
the combination of different computational approaches
and information resources, we have identified genes with
potential functional roles in the early response to heart
injury in the zebrafish; b. we have demonstrated the
potential predictive value of network-based approaches
to systematically dissect complex transcriptional phe-
nomena; and c. we have shown that the identified gene
expression responses and their relationships are repro-
ducible in two in vivo models of heart injury: amputa-
tion and cryoinjury.
A central objective of our study was to show transcrip-
tional response concordance between two in vivo models
of cardiac injury: starting with the traditional one (resec-
tion) and then validating the findings on a more recent,
clinically-motivated one (cryoinjury). In particular, we
aimed to demonstrate that the integrative bioinformatics
analysis of public datasets could result in the identifica-
tion of novel, biologically interesting candidate genes,
whose responses to injury are sufficiently robust or re-
producible across datasets and in vivo models.
The top-15 candidate genes identified in our analysis
are mostly involved in cell fate specification anddifferentiation. Among them, periostin, which regulates
cardiac homeostasis, is a well-known marker of heart
failure [55]. Interestingly, among the 8 genes highlighted
with the RegNet algorithm, some of them were previ-
ously associated with cardiac hypertrophy while others
are still of unknown function in the heart. The central
node, ptgis, codes for prostaglandin I2 (prostacyclin)
synthase, prostacyclin acting as a vasodilator and inhibit-
ing platelet aggregation. Ptgis’s up-regulation was re-
cently shown to be associated with cardiac hypertrophy
and heart failure in rat [56]. Furthermore, recent re-
search has established connections between prostaglan-
dins and regeneration of the brain in zebrafish [57] and
the heart in mice [58].
Likewise, ca2 mRNA and protein expression was also
found to increase during the progression of ventricular
hypertrophy in human [59], suggesting that ca2 could be
a prognostic marker of heart failure. Acta1, encoding
skeletal muscle alpha actin, is one of the major compo-
nents of the contractile apparatus. While the down-
regulation of acta1a in our experiments might only re-
flect a decrease in the number of cardiomyocytes upon
injury, it could also represent a bona fide downregula-
tion of the gene. Indeed, mutations in the acta1 gene in
Figure 6 Predicted relationships between ptgis and its candidate regulated genes are reproduced in the cryoinjury model at day-1
post-injury. Plots show the Log2FC observed in independent qPCR data validation at day-1 (in relation to sham-1d), which are qualitatively
consistent with the associations predicted by the computational model inferred from public data (Figure 2B). Error bars: Standard errors based on
expression variability of 3 biological replicates for experimental and control conditions.
Figure 5 Candidate genes show significant concordance of expression patterns across independent in vivo models at day-3 post-injury.
Log2-transformed fold-changes (FC) observed at day-3 (in relation to controls). Independent observations show strong positive linear relationships
(Pearson correlation coefficient: 0.84, coefficient of determination: 0.71).
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Figure 7 Predicted relationships between ptgis and its candidate regulated genes are reproduced in the cryoinjury model at day-3
post-injury. Plots show the Log2FC observed in independent qPCR data validation at day-3 (in relation to sham-3d). Error bars: Standard errors
based on expression variability of 3 biological replicates for experimental and control conditions.
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in multiple myopathies [60,61]. Among them, nemalin
myopathy is the most common disorder linked to muta-
tion in acta1 gene, and has been occasionally associated
with hypertrophic cardiomyopathy [62-64]. Acta1 ex-
pression was also found to be deregulated in a screen
measuring cardiac gene expression in patients suffering
from hypertrophic cardiomyopathy [65]. Moreover, sarco-
glycans are components of the dystrophin – glycoprotein
complex, which link the actin cytoskeleton to the extracel-
lular matrix in cardiac and skeletal muscle cells. Sgce
codes for epsilon sarcoglycan and is highly homologous to
alpha sarcoglycan (sgca). While sgce null mice do not
display any cardiac phenotype, sgca/sgce double mutant
mice develop dilated cardiomyopathy [66], suggesting a
role for sgce in regulating proper cardiac function. Inter-
estingly, expression of the ubiquitin-specific protease 2a
is down-regulated in our in vivo models of myocardial
infarction. While the role of USP2a has been investi-
gated in cancers, where it has been shown to regulate
p53 pathway or EGFR degradation [67,68], its cardiac
function is still unknown. A recent investigation showed
that a tight control of p53 regulation is a prerequisite for
dedifferentiation and proliferation during limb regener-
ation in the newt [69].
We are aware that additional independent experimen-
tal analyses will be required to confirm or characterize
the potential functional role of our candidate genes. Also
our study is limited by a relatively small amount of
data. To address these constraints and facilitate furtherinvestigations, we have put emphasis on the reduction
of possible false positive relations. This was done by
defining relatively stringent criteria of statistical signifi-
cance, and by applying multiple computational approaches
that were capable to highlight shared associations among
the candidate genes.
Although our results indicate that the candidate genes
are both potentially novel and biologically meaningful
players, at this stage we do not claim that they include
“regulators” of cardiac regeneration. The latter will require
further analysis and functional investigations.
Also, as all models, the cryoinjury technique used in
this investigation does not perfectly reflect what actually
happens during myocardial infarction in humans. Indeed,
the amputation technique does not promote either cell
apoptosis or formation of a fibrotic scar following injury.
The cryoinjury technique circumvents this problem: the
injury promotes cell death and further formation of scar
tissue, as observed in humans [20,21,23,25,26]. However,
cryoinjury does not represent an ischemic damage followed
by reperfusion injury, the common series of events occur-
ring upon a myocardial infarction episode in humans
[32,70]. Moreover, unlike humans, the zebrafish is able to
fully regenerate the heart following injury. Nevertheless, a
deeper understanding of the early steps of the regener-
ation process may allow researchers to reconcile import-
ant differences. Despite these limitations, our analysis
highlighted genes that are known to be involved in heart
failure in other species, such as rodents, and even those
known to play a crucial role in regulating cardiac function
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genes as key regulators of heart regeneration.Conclusions
Because of its potential for translational research, we will
continue investigating heart injury responses in the
zebrafish using the cryoinjury model. We will expand
the scope and depth of our investigations, including
additional biological replicates at post-injury times as
well as different control samples reflecting pre-injury
or non-damaged states. As larger, high-quality datasets
become available at our laboratory and elsewhere, we
will be able to further assess the predictive potential of
our network-based models.
In conclusion, we identified genes with potential critical
roles in the response to cardiac damage in the zebrafish.
Their transcriptional activities are reproducible in dif-
ferent in vivo models of cardiac injury. These findings
motivate additional research to confirm and function-
ally characterize our set of candidate genes. These insights
and the application of network-based computational
models open new opportunities for cardiovascular transla-
tional research.Methods
Animal procedure and cryoinjury model
All procedures were approved by the national authorities
responsible for animal experiments in Luxembourg. Ex-
periments were performed on wild-type adult zebrafish
aged 10–11 months from the WIK strain (ZIRC, Eugene,
OR, USA). Animals were maintained under standard la-
boratory conditions in the Zebtec Stand Alone system
(Tecniplast) at a density of 3 fish/L, at 28°C with day/night
light cycles of 14 h light/10 h dark.
Cryoinjury and hearts dissection were performed as
previously described [24]. Briefly, fish were anesthetized
in 0.04% tricaine (Sigma Aldrich, Bornem, BE) and
placed ventral side up in a damp foam. A small incision
was performed through the body wall and the pericar-
dium, the pericardial sac was opened and the ventricle
exposed by gently compressing the abdomen. The sur-
face of the ventricle was frozen by applying a cryoprobe
previously cooled in liquid nitrogen, until thawing was
observed. Following surgery, fish were placed in a tank
of fresh water, reanimated by gently pipetting water
onto the gills and further housed under standard condi-
tions. Sham operations consisted of opening the body
wall and the pericardial sac, without touching the ex-
posed ventricle. Animals were sacrificed 1 or 3 days after
surgery by immersion in 0.16% tricaine (Sigma Aldrich,
Bornem, BE). Hearts were dissected in PBS containing
heparin and KCl and further used for histological staining
or RNA extraction.Immunohistochemistry
Hearts were fixed overnight in PBS containing 4% para-
formaldehyde, dehydrated and embedded in paraffin
wax. Seven μm sections were cut on a Leica Microtome,
mounted on superfrost slides and dried for 1 h at 45°C.
Samples were deparaffinized in xylol, rehydrated in etha-
nol and washed in distilled water. Heat-induced epitope
retrieval was performed in citrate buffer pH 6. Sections
were blocked for 1 h in 5% BSA – 0.5% tween 20. Primary
anti-tropomyosin antibody was CH1 (DSHB) used at a di-
lution of 1/20. Secondary antibody was Alexa Fluor®568
goat-anti mouse IgG (1/300; Molecular Probes). TUNEL
staining was performed using the in situ Cell Death
Detection Kit, Fluorescein (Roche), according to the
manufacturer’s instructions. Nuclei were stained with
DAPI. Pictures were acquired using a confocal fluores-
cence microscope (Zeiss Laser Scanning Microscope
LSM 510).
Independent validation: RNA extraction, integrity and
reverse transcription
Three to four heart ventricles were pooled per sample in
TRIzol (Invitrogen, Carlsbad, CA) and stored at −80°C
until extraction. Homogenisation of samples was per-
formed with a Polytron® (Bohemia,USA). Aqueous
phase was isolated with Phase lock gel-Heavy (5 Prime,
Gaithersburg, MD), total RNA was precipitated with 100%
isopropanol and purified using RNeasy Micro kit com-
bined with an on-column DNase treatment following
the manufacturer’s instructions (Qiagen, Valencia, CA).
RNA quantity was assessed with a Nanodrop (Thermo
Scientific, Wilmington, USA) and quality was evaluated
with the Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA). RNAs used in the present study were of
good quality and un-degraded (Ratio A260/A280 ≈ 2 and
RIN ≥ 8).
500 ng of RNA were reverse transcribed into cDNA
using the SuperScript III (Invitrogen, Carlsbad, CA) re-
verse transcriptase with the following protocol: RNAs
were mixed with random primers, oligo (dT)12-18 and
dNTPs in a total volume of 13 μl. Samples were heated
to 65°C for 5 min and incubated on ice for at least
1 min. Then the 5X RT buffer, DTT, RNaseOUT and
SuperScript III were added to a total volume of 20 μl.
RT was allowed at 50°C for 60 min and was followed
by enzyme inactivation at 70°C for 15 min. Final con-
centrations were: 100 ng of oligo(dT)12-18, 50 ng of
random primers, 0.5 mM dNTPs, 50 mM Tris–HCl,
75 mM KCl, 3 mM MgCl2, 5 mM DTT, 40U of RNase-
OUT and 200U of SuperScript III. To remove RNA
complementary to the cDNA, 2U of E. coli RNaseH
were added and samples were incubated at 37°C for
20 min. In each RT-PCR a no template control (no
RNA in RT) was performed.
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cDNAs obtained from RT of RNA were diluted 10-fold
and 4 μL were mixed with SYBR®Green Master Mix
(Biorad, Nazareth, Belgium) to a final volume of 20 μL
containing 300nM of each primer. Amplification was
carried out in the CFX96 thermal cycler (BioRad) under
the following conditions: heating for 3 min at 95°C,
40 cycles of denaturation for 30 s at 95°C, followed by an
annealing/extension for 1 min. After each run a melting
curve analysis was performed, ramping from 55°C to 95°C
in 20 min. A negative control without cDNA template
was run in every assay and measures were performed in
duplicates.
Primers were designed with the Beacon Designer Pro
8.10 software (Premier Biosoft, Palo Alto, USA), flanking
an intron. Specificity was assessed using the NCBI
BLAST tool [71], melting curves were performed in
each assay and gene-specific amplification was confirmed
by a single band in 4% E-Gel® (Life technologies). Data
analysis normalization was carried out against three refer-
ence genes; ef1a, rpl13a, tuba1 and expression levels were
calculated using the CFX manager 3.0 software (Biorad) via
the delta-delta Cq method, taking into account the calcu-
lated amplification efficiency for each primers pair. See
Additional file 5 for MIQE checklist [72] and details of
qPCR experiments.
Data pre-processing and differential expression analysis
As we were intended to use already pre-processed micro-
array data, no normalization or probe summarization was
performed in addition to those used in [29,40]. In order to
increase the power of statistical testing for detecting dif-
ferential expressed genes, we performed pre-filtering of
features removing those, which never show expression
over 6 in log2 scale. The cleaned dataset was then ana-
lysed by limma package of R/Bioconductor [73] as it was
described before [74,75]. Finally, a list of features signifi-
cantly regulated at each time point was obtained using the
same “limma” model and a set of contrasts, comparing
time point samples versus controls. To control for false
discovery rates (FDR), we used the Benjamini–Hochberg’s
adjust of P-values. To report changes in gene expression
we used standard heatmaps of R/Bioconductor.
Gene association network models
We generated and analysed gene co-expression networks
with different computational methodologies: Clustering
with Overlapping Neighborhood Expansion (ClusterONE)
[37], inference of gene regression networks with model
trees (RegNet) [38], and the Weighted Gene Co-Expression
Network (WGCNA) algorithm [39]. The capacity of these
techniques to produce biologically informative results
have previously been reported in different biomedical
research applications. These techniques allowed us toidentify: networks clusters, highly connected genes, and
genes that can be used as estimators of the expression
values of other genes in the dataset.
The Clustering with Overlapping Neighborhood Expan-
sion (ClusterONE) algorithm identifies highly cohesive
network clusters (modules) through a 3-step process [37].
First, starting from a seed node, ClusterONE implements
a greedy search of candidate groups showing high cohe-
siveness. This procedure is started from different seed
nodes and leads to the formation of multiple, and possibly
overlapping, clusters. Next, ClusterONE merges clusters
with significant overlaps according to a pre-defined
threshold. In the final step, candidate modules that do
not meet user-defined scores (minimum number of nodes
and module density) are removed from the list of candi-
date modules. Here we used ClusterONE’s plugin (v1.0)
for Cytoscape (v2.8.3) [76] with a minimum number of
nodes of 5, “Auto” minimum density, unweighted clus-
tering, node penalty = 2, haircut threshold = 0; overlap
threshold = 0.8.
RegNet [38] identifies transcriptional association net-
works in three steps. In the first step, an unsupervised
learning algorithm analyses each gene as a target by taking
into account the remaining genes as inputs to a mathem-
atical model that estimates the expression value of that
gene. The mathematical model consists of several linear
models spread over separate areas of the search space, i.e.
optimal partitions of gene expression samples. Each linear
model represents localized similarities between specific
groups of genes. Moreover, the algorithm builds linear
models under all samples (global similarity) if the optimal
subspace is defined by the complete set of gene expression
samples. We have used M5’ model tree algorithm [77] to
build the mathematical model for each target gene. In the
second step, RegNet extracts, as hypothetical evidences of
gene-gene association, the linear dependency that exists
between the target gene and every gene involved in the
linear models of the target gene. This step only includes
those mathematical models that have a relative error less
than a threshold value. The third step involves building a
graph model of gene co-expression network by assessing
the significance of the set of hypothetical evidences using
the Benjamin-Yekutieli procedure for the control of false
discovery rate. In our analysis RegNet was applied with a
threshold value theta = 30%, i.e. the model trees with rela-
tive error greater than theta were removed, and statistical
significance at 0.05.
Module identification was also performed using
Weighted Correlation Network Analysis (WGCNA)
[39]. With WGCNA, weighted correlations are calculated
between genes based on the gene’s expression in the dif-
ferent samples; a weighted correlation is a correlation
raised to a certain power (called the soft thresholding
power). Weighted correlations are used as they are more
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higher correlations over lower correlations (which can
often occur due to chance). In WGCNA, the weighted
correlations are used to create a specific type of network
(a topological overlap network). This network is based on
network topology rather than direct correlations between
genes: genes are strongly linked together in this network if
they share many correlated neighbours with each other.
This topological overlap network is then analysed to
identify network modules of genes that are strongly
linked together. Identifying network modules from the
gene expression in this way focuses on groups of genes
that are predicted to be functionally related based only
on the gene expression data. WGCNA was performed
on genes that were significantly differentially expressed
between at least two conditions across all samples
(FDR < 0.05). The network was constructed by calcu-
lating an adjacency matrix using a soft-thresholding
power of 10 and Spearman correlation using pairwise
complete observations. A topological overlap matrix
(TOM) was then calculated from the adjacency matrix,
converted to distances, and clustered by hierarchical
clustering using average linkage clustering. Modules
were identified with dynamic tree cut with minimum
module size = 20, using the hybrid method. Module
eigengenes were calculated and similar modules were
merged together using a module eigengene distance of
0.15 as the threshold.Additional files
Additional file 1: Dynamic visualization of co-expression network at
different times (PDF) and underlying data (Excel file). In the network
visualizations: nodes are color-coded to reflect Log2FC values (in relation
to control), with scales indicated for each time-specific state.
Additional file 2: Detailed, higher resolution view of Figure 2C.
Additional file 3: Immunohistochemistry on sagittal sections of
sham-operated and cryoinjured hearts recovered one day
post-surgery. A – D: Staining is performed with an antibody against
tropomyosin (red). Note the reduced staining of tropomyosin in the
injured area of the ventricle compared to sham. E –H: TUNEL assay on
hearts recovered one day post-surgery detects a high amount of
apoptotic cells (green) in the cryoinjured area while no staining is
visible in uninjured ventricles. Nuclei are stained with DAPI (blue).
A/C: costaining DAPI/tropomyosin; B/D: staining of tropomyosin
alone. E/G: costaining DAPI/TUNEL; F/H; TUNEL staining alone.
Scale bar is 100 μm. A: atrium; B: bulbus arteriosus; V: ventricle;
IA: injured area. Sham: sham-operated heart recovered one
day post-surgery; 1dpi: cryoinjured heart recovered at
day-1 post-injury.
Additional file 4: Changes in (log2) expression of candidate genes
in independent qPCR data validation with corresponding standard
errors (calculated based on expression variability of 3 biological
replicates for experimental and control conditions). (A) 1 day after
injury vs sham-1d and (B) 3 days after injury vs sham-3d. Central node in
Figures 6 and 7, ptgis, is marked yellow.
Additional file 5: MIQE checklist, including details of qPCR
experiments. Sheet 1: MIQE, Sheet 2: A-Primers B- Normalization data
analysis information.Competing interests
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